Conference Highlights

As pharmaceutical manufacturing continues its transformation through artificial intelligence (AI), automation, advanced analytics, and increasingly digital operations, one critical factor remains at the center of success: people. While new technologies are reshaping every stage of the product lifecycle, organizations are discovering that sustainable transformation depends not only on technology adoption but on workforce readiness, capability development, and effective leadership.

Innovative medicines are advancing across a broad range of therapeutic modalities, from small molecules and biologics to next-generation therapies such as ATMPs, ADCs, radiopharmaceuticals, and mRNA-based products. Yet scientific breakthroughs alone are not enough. Transformative therapies only fulfill their promise when they can be manufactured reliably, scaled efficiently, navigated through regulatory pathways, and ultimately delivered to the patients who need them.

As artificial intelligence (AI), digital transformation, and evolving regulatory expectations continue to reshape the pharmaceutical industry, organizations face a critical challenge: how to innovate while maintaining compliance, quality, and patient safety. The Governance, Risk, and Readiness track at the 2026 ISPE Annual Meeting & Expo, taking place 18–21 October 2026 in Washington, D.C., USA, and virtually, offers a timely and practical roadmap for navigating this new reality.

The pharmaceutical industry has never lacked ambition. Across the globe, scientific discovery continues to move at extraordinary speed. New modalities, advanced therapies, precision approaches, digital platforms, automation, artificial intelligence, and novel manufacturing technologies are expanding what may be possible.

The pharmaceutical industry stands at a defining moment. As organizations accelerate digital transformation, the challenge is no longer just adopting new technologies; it is ensuring those technologies support trustworthy decisions, sustained compliance, and reliable operations. This focus is central to the Digital, Data, and Decision Integrity track at the 2026 ISPE Annual Meeting & Expo, taking place 18–21 October in Washington, DC, United States (and virtually).

As the pharmaceutical industry continues to evolve at an unprecedented pace, the 2026 ISPE Annual Meeting & Expo arrives at a critical moment. With accelerating scientific innovation, evolving regulatory expectations, and increasing global interconnectivity, organizations are being challenged to adapt faster than ever before. This year’s meeting is designed to equip leaders with the tools, insights, and connections needed to navigate uncertainty and deliver with confidence.

The 2026 ISPE Annual Meeting & Expo, taking place 18–21 October in Washington, D.C., will convene global leaders across pharmaceutical engineering, manufacturing, and operations to address one of the industry’s most pressing challenges: how to design and operate systems that consistently deliver safe, high-quality therapies while reducing environmental impact and strengthening system resilience.